Healthcare & Life SciencesReported founding year: 2018~2 peopleSan Francisco, CA, USA
mRNA therapeutics to extend healthspan entering clinical trials
Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1 in longevity trial. 50+ granted patents, 7 patent families. FDA INTERACT cleared. Raising $10M seed extension ($2M+ wired) to fund 3 investigator-initiated trials. Readouts in Q3 2027. $6.8B in comparable mRNA-LNP M&A in last 12 months.
Pressurl: https://news.google.com/rss/articles/CBMijwJBVV95cUxOQzRycVpLT0hicjR2N1piNEJqeUdHVXV3blQ3NnBPVXJPMXZqSkdIQWZUODlQa1Q4cTFiSldqREdOLUdyVFVidldiTDc4c1JhbF9UZG1PYjkxa0tDSEZSRV82YmxkcmowcnBLdWl4N1hYR0ZlUUVacDlVRHNHZG5EVEtCb3ViX01VZVhGOXc5cDJwdWdEeGFtdVp2M1BGeEFjT3Q3QWFZSHoxVU9qeWNqMGo0LXBzWjRQb0dUTFMyX3FoYWd4cGppekxZQ1RtT3VFRVE3NV9pMm5EV2xXNW1pdTZSRlpaWFFaOVRqZ1JNU2Z4RmFkd2ZDZWxmUnFZallXV21pWU5CYS1SWk5DQlZB?oc=5 · headline: Rejuvenation Technologies Raises $10.6M Seed Financing Led by Khosla Ventures to Develop mRNA Therapeutics to Reverse Aging · publication: Business Wiregoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMivAFBVV95cUxNSXlQUWQ5ckdyZW9Pak1aSTNvRmYxbTF1RDU0M2laVUUwOFlhV1ZieExGQmNEakJtWUEyRWFXeVFRNXIxenhOSmpzR2FNdWdJdy1oaDk2d2g2QnJuVlRBUGZSWnJYNW9YdllZNFhxTW1kQnBlVjRDdjZyOTlKN2lsc2VzZmRXeGJYaTNUNzE3OVU0cC1qMmV3MjZZS0F2Wlh5SU5TNWx1NFEzS09mUlFoa1lJSEJfdVhhTk1VNQ?oc=5 · headline: A ‘pioneering’ process for spent cell culture media: Rejuvenation tech expected to bring down price of cultivated meat · publication: FoodNavigator.comgoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiwAFBVV95cUxNYkQxQXZqS1F0UXV6azZCNVNxREM4T1BPQk9NWGo3dmZvcm5SRnN4OTQ5R21IekFCVU1weG9xZy1xeDdPSzE1ajI4RE96bUVpYnRfR2VDNjZEYlVpQXhUR0Q0RWRGb1VhdWJmM2hPQVFwMHpKRi1RWjZfcWtEWGVISm9oUU1OckJLaFc1a0VOdTNIbVRZZmxUYWJZcGF0aUtCQVdxM1BJd1J3QkZIUkRUazhqZkU3SEJjTUY1TTFDWFA?oc=5 · headline: Billionaires Bankroll Cell Rejuvenation Tech as the Latest Gambit to Slow Aging · publication: Scientific Americangoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi4AFBVV95cUxOeDlXSDV1bHhvZjB3V2JGT1RiT2dqek5rRVgycWhKU3hzRlJXTjNHRVBORmg3aTVHSUc0WXZqa195SmhfdW5PdmVCMW1JSUJQcnpvRTUtSFRxTDlBQ2NGUFFGSW1pcU5GY1h5dG1mb2NJSU55bjhFNjlINjZ4NnVxZUM3R3JBZVF2dTZWdVZJcHRxazMzZ3RwdmxfSHpQcU42QnEybGI4cW15VVlMTXVHYUVIazJuYnZhMjNfS0ptdXIzakJHZVZ3Mmt5SXRtZWlGdDhYc0lwSjMtQXpRQ01rSg?oc=5 · headline: Rejuvenation Technologies Raises $10.6M Seed Financing Led by Khosla Ventures to Develop mRNA Therapeutics to Reverse Aging · publication: BioSpace
Billionaires Bankroll Cell Rejuvenation Tech as the Latest Gambit to Slow Aging